Publication | Closed Access

Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury

NeuropsychologyCognitive PerformanceNeurophysiologyMedicineExperimental Brain InjuryNmda Partial AgonistNeuropharmacologyBrain InjuryNeurologyNeuroprotectionNeuroscienceNeurorehabilitationCognitive RehabilitationNeurochemistryPost-injury AdministrationSocial Sciences